Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioInvent International AB
DescriptionHuman mAb against intercellular adhesion molecule-1 (ICAM-1; CD54)
Molecular Target Intercellular adhesion molecule-1 (ICAM-1) (CD54)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple myeloma (MM)
Indication DetailsPrevent or delay relapse of multiple myeloma (MM); Treat multiple myeloma (MM)
Regulatory Designation U.S. - Orphan Drug (Treat multiple myeloma (MM));
EU - Orphan Drug (Treat multiple myeloma (MM))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today